Form C - Offering Statement:
SEC Accession No. 0001670254-23-000721
Filing Date
2023-07-20
Accepted
2023-07-20 13:27:39
Documents
14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 11502
2 document_1.pdf EX-99 6140439
3 document_2.pdf EX-99 2179509
4 document_3.pdf EX-99 19623991
5 document_4.pdf EX-99 19620341
6 document_5.pdf EX-99 12672407
7 document_6.pdf EX-99 12672170
8 document_7.pdf EX-99 10371002
9 document_8.pdf EX-99 1006594
10 document_9.pdf EX-99 1898413
11 document_10.pdf EX-99 2872708
12 document_11.pdf EX-99 2172754
13 document_12.pdf EX-99 742820
14 documents_list.htm EX-99 123
  Complete submission text file 0001670254-23-000721.txt   124365748
Mailing Address 2265 E FOOTHILL BLVD PASADENA CA 91107
Business Address 2265 E FOOTHILL BLVD PASADENA CA 91107 6282664770
InvVax, Inc. (Filer) CIK: 0001973591 (see all company filings)

EIN.: 800890828
Type: C | Act: 33 | File No.: 020-32646 | Film No.: 231099092